CRP and rheumatoid arthritis: To evaluate the clinical effects of tocilizumab in the RA patient, WBC, Hb, ferritin, ESR/CRP, and IL-6 were assessed at baseline, 1st, 3rd, and 6th months of tocilizumab treatment.